Glioblastoma (GBM) is the most common form of primary brain cancer, and is widely recognized as one of the deadliest forms of cancer. Approximately 10,000 patients are diagnosed with GBM each year in the United States, and there are very limited treatment options for recurrent disease.
However, there is hope: a new available treatment option for GBM is on the horizon. Optune is a new FDA approved device for the treatment of adult patients (22 years of age or older) with recurrent glioblastoma (GBM). With Optune, patients can have the effectiveness of chemotherapy without the debilitating side effects that traditional chemotherapy can bring. Optune offers people living with GBM a better quality of life.
Treating Brain Cancer With A Portable Device
Dr. Steven Toms of Geisinger-Community Medical Center’s Neuroscience Institute, PA recently shared more details about treating brain cancer with a portable device. Dr. Toms explained how this unique device works, who is eligible for the treatment, and his experience treating patients with the device.
Optune is available by prescription from a certified healthcare provider. For more information about treating brain cancer with a portable device and Optune, visit: www.novottftherapy.com.